Mingsheng Huang
?
Titles
Dr. Mingsheng Huang is a consultant radiologist at the Third Affiliated Hospital of Sun Yat-sen University. He is vice-director of the Department of Vascular Interventional Radiology of the Third Affiliated Hospital of Sun Yat-sen University and the head of the Department of Vascular Interventional Radiology of the Lingnan Hospital of Sun Yat-sen University. Dr. Huang is Associate Professor of Medicine at Sun Yat-sen University responsible for graduate education of master’s degree candidates.
Dr. Mingsheng Huang is the vice chair of the Interventional Radiology Committee of the Board of Young Fellows of Chinese Medical Society of Radiology. He is a fellow of the Youth committee of the Board of Interventional Radiologists of Chinese Medical Doctor Association and a member of the Expert Panel of Visceral Artery Diseases of the same association. He serves as fellow in the Board of Interventional Radiologists of Guangdong Medical Doctor Association. He serves on the Expert Panel of Minimally Invasive Interventions of Chinese Chapter of International Hepato-Pancreato-Biliary Association and the Expert Panel of Clinical Governance of Imaging Centers of Guangdong Hospital Association.
?
Research Interest?
? Interventional radiology
? Prevention of neoplasm recurrence and metastasis
? Molecular targeted therapy for liver cancer
His early work focused on (1) the measure of renal function at time points during the initial recovery from ischemia renal injury with function dynamic CT, and the cellular and molecular factors involved in the functional and morphologic changes in ischemic acute renal failure model; (2) the functional MRI imaging in monitoring the effect of apoptosis-inducing agent on liver malignant tumor in rats. Now he concerns about the mechanisms and targeted therapy of cancer recurrence and metastasis after interventional local therapy of hepatocellular carcinoma.
?
Education and Experience
Education
Bachelor: Sun Yat-Sen University of Medical Sciences, China (1989-1994)
Master: Sun Yat-Sen University of Medical Sciences, China (1998-2001)
M.D., PhD.: Sun Yat-Sen University (2004-2007)
Training
The first Affiliated hospital of Sun Yat-Sen University, China (1993)
Guangdong General Hospital, China (1994)
Visiting Fellow: ?Asan Medical Center, Korea (2002)
Postdoctoral research fellow: ?Indiana University, USA (2008-2009)
Visiting Fellow: Beaumont Hospital, Ireland(2012)
Residencies
Radiology department of the third affiliated hospital, Sun Yat-Sen University, China(1994-1997)
Interventional vascular division, Radiology department of the third affiliated hospital , Sun Yat-Sen University, China(1998-2000)
The Attending Physician
Division of vascular Interventional Radiology, the third affiliated hospital , Sun Yat-Sen University, China (2001-2006)
Associate Professor and Consultancy
Department of Vascular Interventional Radiology, the Third Affiliated Hospital , Sun Yat-Sen University, China (2007-Present)
Department of Vascular Interventional Radiology, Lingnan Hospital , Sun Yat-Sen University, China (2012-Present)
?
Honors and Awards
First prize of Ministry of Education Technological Progress Award, scientific program of “Clinical series studies of interventional treatment for portal hypertension causing by different etiologies”
First prize of Guangdong Province Science and technology progress award, scientific program of “ Series studies of imaging and interventional diagnosis and treatment technology in the perioperative period of liver transplantation”.
?
Publications
1.Huang M, et al. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study. Eur Radiol. 2016 Jan 20. [Epub ahead of print]
2.Huang M, et al. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. Int J Oncol. 2016 May;48(5):2144-54.
3.Huang M, et al. The use of coronary stent in hepatic artery stenosis after orthotopic liver transplantation. European Journal of Radiology, 2006, 60（3）：425~430
4.Huang M, et al. Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World Journal of Gastroenterl, 2004, 10(6): 825
5.Huang M, et al. Percutaneous Intervention in the Treatment of Hepatic Artery Stenosis or Occlusion After Orthotopic Liver Transplantation. 2008, SIR.
6.Huang M, et al. The evaluation of quality of life associated with uterine artery embolization in the treatment of leiomyoma. Chinese Journal of Radiology (Chinese), 2002, 36: 877-880.
7.Huang M, et al. Implanted percutaneous continous continuous hepatic arterial infusion system for nonresectable liver metastasis. Chin J Oncol (Chinese), 2001,23(6): 493-496
8.Huang M, et al. One-shot infusion methotrexate combined with embolization via uterine artery for treatment of fallopian tubal pregnancy. Chin J Med Imaging (Chinese), 2001, 9(1):39-41
9.Huang M, et al. Value of the treatment of massive hemoptysis due to pulmonary tuberculosis by superelective bronchial artery embolization. Journal of Interventional Radiology (Chinese), 2000, 9(2): 79-81
10. Huang M, et al. Stents endoprosthesis for the treatment of malignant colonic obstruction. Journal of Interventional Radiology (Chinese), 1999, 8(2): 118-1203. 11. Lin ZH, Li X, Hong YF, Ma XK, Wu DH, Huang M, Chen ZH, Chen J, Dong M, Wei L, Wang TT, Ruan DY, Lin ZX, Zhong X, Xing YF, Wen JY, Wu XY, Lin Q. Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization. Tumour Biol. 2016 Mar;37(3):2951-9. PMID: 26411670
12. Lai L, Chen J, Wei X, Huang M, Hu X, Yang R, Jiang X, Shan H. Transplantation of MMSCs Overexpressing HGF into a Rat Model of Liver Fibrosis. Mol Imaging Biol. 2016 Feb;18(1):43-51. PMID: 26194009
13. Cai M, Huang W, Lin C, Li Z, Qian J, Huang M, Zeng Z, Huang J, Shan H, Zhu K. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
Eur Radiol. 2016 Feb;26(2):370-80. PMID: 26002134
14. Wu C, Li D, Ren L, Hu X, Jiang Z, Zhu K, Huang M, Guan S, Shan H. [Application of hepatocellular carcinoma targeted multifunctional nanocarriers]. Zhonghua Yi Xue Za Zhi. 2014 Dec 23;94(47):3767-70. Chinese. PMID: 25623105
15. Pang P, Li B, Hu X, Kang Z, Guan S, Gong F, Meng X, Li D, Huang M, Shan H. [Multifunctional nano-vector for gene delivery into human adipose derived mesenchymal stem cells and in vitro cellular magnetic resonance imaging]. Zhonghua Yi Xue Za Zhi. 2014 Apr 8;94(13):1021-4. Chinese. PMID: 24851693
16. Pang P, Jiang Z, Huang M, Zhou B, Zhu K, Shan H. Value of endovascular stent placement for symptomatic spontaneous isolated superior mesenteric artery dissection. Eur J Radiol. 2013 Mar;82(3):490-6. PMID: 23092539
17. Babsky AM, Ju S, George B, Bennett S, Huang M, Jayaram HN, McLennan G, Bansal N. Predicting response to benzamide riboside chemotherapy in hepatocellular carcinoma using apparent diffusion coefficient of water. Anticancer Res. 2011 Jun;31(6):2045-51. PMID: 21737621
18. Wang X, Li J, Huang M, Kang L, Hu M. A study on Fu-Yuan Pellet, a traditional chinese medicine formula for detoxification of heroin addictions. Am J Drug Alcohol Abuse. 2009;35(6):408-11. PMID: 20014908
19. Zhu K, Meng X, Li Z, Huang M, Guan S, Jiang Z, Shan H. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study. Eur J Radiol. 2008 Apr;66(1):100-6. PMID: 17532166
?
Contact
Interventional Vascular Division,
Department of Radiology,
The 3rd Affiliated Hospital, Sun Yat-Sen University,
600 Tianhe Road
Guangzhou, 510630
P.R.China
Telephone: 0086-2082179035
E-mail: Email: huangmsh@mail.sysu.edu.cn
